Code | 65257 | ||||||||||
MA number | EU/1/08/497/001 | ||||||||||
Product Form: | plv ino 1x250 µg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Amgen Europe B.V., Netherland | ||||||||||
Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 60 | ||||||||||
Container: | glass container | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 04.02.2009 |
SmPC + PL: |
|
Dokument: |
|
Dokument: |
|
Dokument: |
|
Dokument: |
|
Dokument: |
|
Dokument: |
|
Dokument: |
|
Dokument: |
|
Safety feature | Yes |
Data update: | 19.06.2018 |